Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms
Author(s)
Ng, AP;
Details
Publication Year 2013-05,Volume 54,Issue #5,Page 922-933
Journal Title
LEUKEMIA & LYMPHOMA
Publication Type
Journal Article
Abstract
The understanding of myeloproliferative neoplasms has changed dramatically since Dameshek proposed his classification over 50 years ago. Our knowledge of the types of cells which constitute the hematopoietic system and of how they are regulated has also appreciated significantly over this time. This review relates what is currently known about the acquired genetic mutations associated with adult myeloproliferative neoplasms to how they lead to the hematopoietic perturbations of myeloproliferative disease. There is a particular focus on how stem and progenitor cell compartments are affected by BCR-ABL1 and JAK2V617F mutations, and the particular issue of resistance of leukemic stem cells to conventional and targeted therapies.
Publisher
INFORMA HEALTHCARE
Keywords
CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; COLONY-STIMULATING FACTOR; COMPLETE MOLECULAR REMISSION; PLUS INTERFERON-ALPHA; EARLY CHRONIC PHASE; RENEWAL IN-VIVO; POLYCYTHEMIA-VERA; BCR-ABL
Research Division(s)
Cancer And Haematology
Terms of Use/Rights Notice
Copyright © 2012 Informa Plc. All rights reserved.


Creation Date: 2013-05-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙